Swedish

Karolinska Biobank

The Karolinska Institute (KI) Biobank is a modern and high-tech infrastructure for pre-analytical handling, storage and distribution of human biological samples. In total the collection comprises more than 8 million samples, including 120 registered collections, varying in size from a few hundred sample donors up to tens of thousands. KI Biobank provides services for collection, handling, storage and traceability of biobank samples, and supports customers both within and outside of Karolinska Institute.

Key facts

Name of the connected EIT Health partner:Karolinska Institute
Number of individuals:Total ~500,000
Biobank confirmed willingness to provide samples/data for EIT Health studies:KI biobank contains a large number of sample collections that are saved for research purposes. After ethics approval, permission from the biobank custodian and permission from the PI or committee granting access to the respective samples, samples may be available for EIT- Health studies.
Contact person(s) and contact data
(e-mail address, tel. no) for access purposes:
The sample collections are usually available for collaborations after contact with the responsible researcher or contact: biobank@ki.se https://ki.se/forskning/ki-biobank
Number of samples:Total ~8 million
Sample type:The most common types are blood and DNA but other sample types, such as plasma, serum, saliva, urine, cerebrospinal fluid are also collected.
Website:This varies from study to study, and data availability is entirely dependent on PI agreement to share data.
Website:Karolinska Institute (KI)

General information

Type of biobank:KI biobank is a research biobank. There are many different types of sample collections. Currently 250 collections are registered in the biobank. The collections vary in size from a few hundred sample donors up to tens of thousands and contain different types of samples.
If longitudinal the frequency:Not available.
Link to central portal to seek samples and data:http://bbmriregister.meb.ki.se:8080/AwareIM/
logonGuest.aw?domain=BBMRIRegister
Broad consent:Requires approval from the Swedish  Ethics Review Authority.
Option to recall donors:Varies from collection to collection.
Option to recall family members:Varies from collection to collection.

Biobank access procedure:

Major terms for access:Samples can be made available to research groups and companies after a decision from the ethical review authority, application to biobank custodian and permission from the group or committee granting access to the respective samples. 
Ethical and legal compliance:When all conditions are agreed the service is very reliable. 
Speed and reliability of delivery:Delivery times depend on scale of order but are always competitive.
Pricing:Prices are according to our published price list.

Quality management system:

Storage:Storage of samples is at -20, -80 and -190 C depending on sample type.
Compliance with international standards:Conforms to SPREC.
Current ISO certificates:KI biobank is not ISO certified.

Data:

Clinical data linked to samples:Dependent on agreement to share data.
Data standards:Normal standards of data security, quality and integrity are in operation.
Data security rules:Normal standards of data security, quality and integrity are in operation.

Biobank related service:

Research support, what type of expertise?:Biobank services cover three main areas:
1) Study start-up and advice throughout the different phases of the research study
2) Sample handling and IT-system for traceability
3) sample registration.
Core facility services; what type? Link?:Not available.
Queries from national health registers:Not available.
Links to the model contract and MTA:https://biobanksverige.se/research/useful-resources/application-form-selector/

IP:

IP rules, what is negotiable?:Not available.
Requirements to study results (access etc.):Not available.
Participant’s right to the information:Not available.
Number of access contracts with industry:We have 5 industrial customers at present

The "Registers and Biobanks in Transition” strategic initiative is funded by EIT Health